Donepezil Hydrochloride; Memantine Hydrochloride Capsule, Extended Release — FDA Drug Shortage

To Be Discontinued — Amneal Pharmaceuticals

The FDA lists a drug shortage record for Donepezil Hydrochloride; Memantine Hydrochloride Capsule, Extended Release (capsule, extended release) from Amneal Pharmaceuticals with status To Be Discontinued. The shortage was first posted on Jun 15, 2026.

Shortage details

Status
To Be Discontinued
Company
Amneal Pharmaceuticals
Package NDC
69238-1247-3
Dosage Form
Capsule, Extended Release
Presentation
Donepezil Hydrochloride; Memantine Hydrochloride, Capsule, Extended Release, 10 mg; 28 mg (NDC 69238-1247-3)
Initial Posting
Jun 15, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.